Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Enable Injections Expands Cincinnati, Ohio, Workforce

11/02/2022
Enable Injections, Inc., a company developing and manufacturing the enFuse platform of investigational wearable drug delivery systems, will increase its workforce in Cincinnati, Ohio. The project is expected to create 257 jobs.

The company will benefit from Ohio's Job Creation Tax Credit (JCTC) program, approved by the Ohio's Tax Credit Authority Board. The JCTC and pending additional support from JobsOhio could potentially total more than five million ($5MM) in funding, allowing Enable Injections to invest in further development in the Cincinnati area.

"Enable Injections has experienced strong growth in the Cincinnati area since 2010, developing the enFuse, an innovative drug delivery technology which has the potential to positively impact patient experience worldwide. Enable Injections is proud to be established in Cincinnati and is on a clear path to create more high-tech, high-value jobs and opportunities for our city and State of Ohio," said Mike Hooven, President and CEO of Enable Injections. "We are relentless in our pursuit of transformative and impactful drug delivery technology, and in our commitment to expand our presence in the region."

The State of Ohio, JobsOhio, and REDI Cincinnati all provided support for the expansion.

"Enable Injections is an innovative leader in healthcare technology that has experienced tremendous growth in Ohio," noted J.P. Nauseef, JobsOhio president and CEO. "Its expansion and creation of hundreds of new jobs in the Cincinnati market over the last 11 years reaffirms the strong partnership that Ohio and Enable Injections have built due in part to the competitive advantages businesses find here, including a highly-skilled workforce and affordable cost of doing business."

"Enable, which has roots within our partner CincyTech's portfolio, has been on a rapid expansion since 2015 and we are proud to support its growth in the Cincinnati region," added Kevin Donnelly, REDI Cincinnati's vice president for project management. "This success can be attributed to several factors, exceptional products and strong company leadership from Mike and Tim, a region that fosters growth due to access to STEM and manufacturing talent afforded through our robust educational environment and support from a business community that was recently ranked a top-25 national tech hub by BestColleges."

Cincinnati-based Enable Injections is a global healthcare innovation company developing and manufacturing drug delivery systems designed to improve the patient experience. Enable's body-worn enFuse® delivers high-volume pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting superior outcomes, and advancing healthcare system economics.

Share

Exclusive Research